US Patent Issued to The Johns Hopkins University on Sept. 9 for "Anti-cancer spirocyclic-guanidine compounds and uses thereof" (Maryland Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,141, issued on Sept. 9, was assigned to The Johns Hopkins University (Baltimore).

"Anti-cancer spirocyclic-guanidine compounds and uses thereof" was invented by Richard B. S. Roden (Baltimore) and Ravi K. Anchoori (Baltimore).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention of the instant application discloses spirocyclic guanidine compounds of general formula (I), shown below, and their use in methods of treating cancer"

The patent was filed on May 18, 2021, under Application No. 17/925,923.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=...